The rationale for naltrexone therapy as an alternative to methadone treatment for opiate addiction

Connecticut Medicine

Volumn 60, Issue 11, 1996, Pages 683-685

  Simon, David L ^a,b  

^a Nutmeg Intensive Rehab Center   (United States)

^b Amer Society of Addiction Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; CLONIDINE; DIAMORPHINE; METHADONE; NALTREXONE; OPIATE RECEPTOR;

DETOXIFICATION; DRUG COST; DRUG DEPENDENCE TREATMENT; DRUG WITHDRAWAL; HUMAN; OPIATE ADDICTION; SHORT SURVEY; SUBSTITUTION THERAPY;

HUMANS; METHADONE; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; OPIOID-RELATED DISORDERS;

EID: 0029944903     PISSN: 00106178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (26)

1. Blansfield HN: Inadequate treatment of opioid dependence due to society's attitudes and beliefs. Conn Med 1996; 60:423-8.
2. Lewin and Associates: Legislative Report on Mental Health and Addiction Services in Connecticut, 1995.
3. Resnick R, Kastenbaum R, Washton A, et al: Naloxone-precipitated withdrawal: A method for rapid induction on to naltrexone. Clin Pharmacol Ther 1977; 21:409-3.
4. Kleber HD, Topazian M, Gaspari J, et al: Clonidine and naltrexone in the outpatient treatment of heroin withdrawal. Am J Drug Alcohol Abuse 1987; 13:1-17.
5. Vining E, Kosten TR, Kleber HD: Clinical utility of rapid clonidine-naltrexone detoxification for opioid abusers. Brit J Addict 1988; 83:567-75.
6. Senft RA: Experience with clonidine-naltexone for rapid opiate detoxification. J Substance Abuse Treatment 1991; 8:257-9.
7. O'Connor PG, Waugh ME, Carroll KM, et al: Primary care-based ambulatory opioid detoxification: The results of a clinical trial. J Gen Intern Med 1995; 10:255-60.
8. Presslich O, Loimer N: Opiate detoxification under general anesthesia by large doses of naloxone. Clin Toxicol 1989; 27:263-70.
9. Loimer N, Schmid R, Lenz K, Grunberger J: Acute blocking of naloxone-precipitated opiate withdrawal symptoms by methohexitone. Brit J Psychiatry 1990; 157:748-52.
10. Legarda JJ, Gossup M: A 24-hour inpatient detoxification treatment for heroin addicts: A preliminary investigation. Drug Alcohol Dep 1994; 35:91-3.
11. Presentation at the American Society of Addiction Medicine 27th Annual Medical-Scientific Conference, Atlanta, Georgia, 1996.
12. Sawicki T: The miracle cure? A revolutionary and highly controversial treatment for heroin addiction is achieving astounding success in Israel, and is now set to go overseas. The Jerusalem Report, 13 July 13 1995, pp. 20-21.
13. All Things Considered: National Public Radio Broadcast. 9 July 1996.
14. Gerra G, Marcato A, Caccavari R, et al: Clonidine and opiate receptor antagonists in the treatment of heroin addiction. J Substance Abuse Treatment 1995; 12:35-41.
15. Herman BH, Czechowicz D: NIDA Scientific Report of Ultra Rapid Detoxification with Anesthesia (UROD): Opinion of the Consultants and Criteria Relating to Evaluating the Safety and Efficacy of UROD. 23 February 1996.
16. American Hospital Formulary Services Manual. 1996; p. 1477. ISBN: I-879907-61-5.
17. Stoelting RK: Opiod Agonists and Antagonists. In: Pharmacology and Physiology in Anesthetic Practice. Philadelphia, Pennsylvania: J.B. Lippincott Company; 1987: chap 3.
18. Wilcox RE, Gonzales RA, Erickson CK: Basic Science of Addiction. In: Principles of Addiction Medicine. Chevy Chase, Maryland: American Society of Addiction Medicine. 1994: sect, chap 3.
19. Cvejic S, Trapaidze N, Cyr C, et al: Thr353, located within the COOH-terminal tail of the delta opiate receptor, is involved in receptor down- regulation. J Biol Chem 1996; 271:4073-6.
20. Baumhaker Y, Gafni M, Keren O, et al: Selective and interactive down- regulation of μ- and delta-opioid receptors in neuroblastoma SK-N-SH cells. Mol Pharmacol 1993; 44:461-7.
21. Kim DS, Chin H, Klee WA: Agonist regulation of the expression of the delta-opioid receptor in NG108-15 cells. FEBS letter 1995; 376:11-4
22. Personal communication from J. Thomas Payte, M.D.
23. Yoburn BC, Shah S, Chan K, et al: Supersensitivity to opioid analgesics following chronic opioid antagonist treatment: Relationship to receptor selectivity. Pharmacol Biochem Behav 1995; 51:535-9.
24. Marley RJ, Shimosato K, Gewiss M, et al: Long-term sensitization to the behavioral effects of naltrexone is associated with regionally specific changes in the number of μ and delta opioid receptors in rat brain. Life Sci 1995; 56:767-74.
25. Azatian A, Papiasvilla A, Joseph H: A study of the use of clomdine and naltrexone in the treatment of opioid addiction in the former USSR. J Addict Dis 1994; 13:35-52.
26. Kleber HD, Topazian M, Gaspari J, et al: Clonidine and naltrexone in the outpatient treatment of heroin withdrawal. Am J Drug Alcohol Abuse 1987; 13:1-17.